Free U.S. Shipping on Orders $100+•$10 Flat-Rate Shipping Under $100
BACK TO LIBRARY
CELLULAR & REGENERATIVE RESEARCH

NAD+

Also known as: Nicotinamide adenine dinucleotide · NAD

Nicotinamide Adenine Dinucleotide

EVIDENCE: EARLYBASIC BIOLOGY ESTABLISHED; SUPPLEMENTATION OUTCOMES STILL UNDER STUDYFOR RESEARCH PURPOSES ONLY.
QUICK FACTS

COMPOUND CLASS

Endogenous cellular coenzyme

PRIMARY PATHWAY

Cellular redox reactions and sirtuin/PARP signaling

PRIMARY AREAS OF RESEARCH

Mitochondrial energy metabolism, cellular aging biology, DNA repair

RESEARCH STATUS

Basic biology established; supplementation outcomes still under study

EVIDENCE LEVEL

Early

OTHER NAMES

Nicotinamide adenine dinucleotide, NAD

What Is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is not a drug or a peptide. It is a coenzyme — a small helper molecule that enzymes need in order to do their jobs. Your cells make it from vitamin B3 and use it constantly.

Its main role is to carry electrons during the process of turning food into usable energy. It is also consumed by several important enzyme families, including DNA repair enzymes and sirtuins, which are proteins involved in regulating metabolism and gene activity.

One well-documented observation is that NAD+ levels measured in tissues tend to decline with age. Why that happens, and what it means, is one of the central questions in the field.

What it is
A coenzyme — a helper molecule that nearly every cell in the body needs to produce energy.
Category
Cellular and metabolic research molecule.
Main system involved
Mitochondrial energy production, DNA repair enzymes, and sirtuin signaling.
Research interest
Cellular energy, aging biology, DNA repair, and metabolic health.
Research status
Its core biochemistry is textbook science; supplementation and anti-aging claims remain an active, unsettled research area.

Why Are Researchers Interested?

ESTABLISHED

It is fundamental biochemistry

The role of NAD+ in energy metabolism and redox reactions is established, textbook-level science.

PRECLINICAL RESEARCH

The age-related decline

Declining tissue levels with age are consistently reported. Whether raising them changes aging outcomes is not established.

EARLY CLINICAL RESEARCH

Sirtuins and DNA repair

NAD+-consuming enzymes link cellular energy status to DNA repair and gene regulation — a major research theme.

LIMITED RESEARCH

Supplementation research

Precursors such as NR and NMN have been studied in human trials. Results so far show that levels can be raised; clinical benefits are less clear.

How It Works

Think of NAD+ as a rechargeable shuttle. It picks up electrons in one part of the cell and drops them off in the mitochondria, the compartments that generate most of the cell's energy. It flips between two forms, NAD+ and NADH, over and over.

Separately, certain enzymes consume NAD+ rather than recycle it. DNA repair enzymes called PARPs use it up when they fix damage, and sirtuins use it to adjust cellular programs. Because these enzymes draw from the same pool, researchers describe NAD+ as a hub connecting energy supply, repair, and regulation.

Current Areas of Research

LABORATORY RESEARCH

Mitochondrial energy

How NAD+ availability affects the cell's ability to produce energy.

ANIMAL RESEARCH

Aging biology

Why levels decline with age and whether that decline drives functional changes.

HUMAN CLINICAL RESEARCH

DNA repair

How repair enzymes consume NAD+ and compete with other pathways for it.

THEORETICAL MECHANISM

Sirtuin regulation

How these enzymes translate energy status into changes in gene activity.

HUMAN CLINICAL RESEARCH

Precursor supplementation

Human trials of NR and NMN measuring whether tissue levels actually rise and what follows.

What Does the Evidence Actually Say?

EARLY

Early — NAD+ biology itself is established textbook biochemistry, but human trials of raising NAD+ levels and the resulting clinical outcomes are small and ongoing.

Side Effects & Safety Research

NEUTRAL SUMMARY OF PUBLISHED SAFETY RESEARCH

Documented in research

  • Human precursor trials (such as nicotinamide riboside) have generally reported good short-term tolerability.

Possible or theoretical

  • Flushing and gastrointestinal effects are reported with some NAD+ precursors.

Where evidence is insufficient

  • Long-term effects of sustained NAD+ elevation in humans are unknown.

What We Don't Know Yet

LIMITS OF THE CURRENT EVIDENCE
  • Raising NAD+ levels is achievable in studies, but whether that produces meaningful health outcomes in humans is not established.
  • Much of the striking data comes from animal and cell models that do not always translate.
  • Which tissues matter most, and whether raising levels everywhere is desirable, remains unclear.
  • Long-term effects of sustained supplementation have not been characterized.

Frequently Asked Questions

Research References

  • Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science, 2015.
  • Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism, 2018.
  • Cantó C, Menzies KJ, Auwerx J. NAD+ metabolism and the control of energy homeostasis. Cell Metabolism, 2015.

Key Takeaway

KEY TAKEAWAY

NAD+ is a coenzyme essential to energy production, DNA repair, and the regulation of cellular programs. Its core biochemistry is firmly established, and the age-related decline in tissue levels is a consistent research observation. Whether raising NAD+ levels produces meaningful benefits in humans remains an active and unresolved research question.

Related Research

This information is provided for educational purposes only and summarizes current areas of scientific research. It is not medical advice, a treatment recommendation, or an instruction for personal use. Research findings may be preliminary, limited, or subject to change as new evidence becomes available.